MAVIRET® (glecaprevir/pibrentasvir) registered in Australia for acute hepatitis C virus infection
Further details:
Unless otherwise specified, all product names appearing in this internet site are trademarks owned by or licensed to AbbVie Inc., its subsidiaries or affiliates. No use of any AbbVie trademark, trade name, or trade dress in this site may be made without the prior written authorization of AbbVie Inc., except to identify the product or services of the company.
AbbVie acknowledges the Traditional Custodians of Country throughout Australia and their continuing connection to land, waters and community. We pay our respect to them and their cultures, and Elders, past and present.
Copyright © 2026 AbbVie Inc. North Chicago, Illinois, U.S.A.
